Answers are grounded in this paper and cite their sources.
Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29-2.46) and 1.62 (95% CI, 1.43-1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25-0.70) times less likely to develop severe disease.
No takes yet. Share an insight, caveat, or question.
Premikha et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: